WASHINGTON, DC — Members of the House Judiciary Committee on Thursday voted in favor of legislation (HR 5634: The Medical Cannabis Research Act of 2018) to facilitate federally-approved clinical trials assessing the efficacy of whole-plant cannabis. The vote marks the first time that lawmakers have ever decided in favor of easing existing federal restrictions which limit investigators ability to clinically […]
The National Organization for the Reform of Marijuana Laws Political Action Committee (NORML PAC) has announced their most recent slate of bi-partisan reelection endorsements for incumbent members of the United States House of Representatives. “There was more momentum behind federal marijuana law reform in 2018 than in any previous year, and that is in no […]
Lawmakers have removed language from pending federal legislation that sought to facilitate veterans’ access to medical cannabis in jurisdictions that regulate it. The decision to strip out the Veterans Equal Access Amendment flies in the face of the horrific medical realities that our nation’s heroes who are desperate to mitigate. This move thwarts the will of the […]
Last Friday, the Congressional Black Caucus (CBC) announced its position on various marijuana law reforms. “Some of the same folks who told African Americans ‘three strikes and you’re out’ when it came to marijuana use and distribution, are now in support of decriminalizing the drug and making a profit off of it,” CBC Chairman Cedric L. […]
WASHINGTON, DC — Sixty-six members of Congress representing both Republicans and Democrats sent a letter on Wednesday to Speaker Ryan, Senate Majority Leader McConnell, Leader Pelosi, and Leader Schumer urging them to maintain the federal protections for the 46 states that have implemented some form of medical cannabis programs throughout the country. This comes on […]
Members of the US House Committee on Veteran’s Affairs are demanding the Department of Veterans Affairs facilitate protocols to assess the efficacy of medical cannabis in veterans suffering from chronic pain and post-traumatic stress. Minnesota Democrat Tim Walz, along with nine other Democrat members of the Committee, authored an October 26, 2017 letter to VA […]
Today is National Voter Registration Day and we are pleased to present this valuable voter education tool to the marijuana movement: NORML’s updated and revised 2016 Congressional Scorecard. The Scorecard is an all-encompassing database that assigns a letter grade of ‘A’ (the highest grade possible) to ‘F’ (the lowest grade possible) to members of Congress […]
Congressional Democrats have proposed a legislation which hopefully makes it easier to sue manufacturers of medical devices. Well, it is just a proposal! The question now is whether the proposed legislation has enough votes to pass. No doubt it will be a difficult measure to muster enough votes for either in the House or Senate.
The Medical Device Safety Act of 2009 would overturn the Court’s 2008 ruling in Riegel v. Medtronic, which dismissed a lawsuit over a ruptured catheter. That ruling brought whoops of joy from medical device firms, who had long lobbied for a position that federal law blocked, or preempted, such suits. But the Supreme Court changed the landscape yesterday in Wyeth v. Levine when it upheld a $ 6.7 million state jury verdict won by a musician from Vermont whose arm was amputated after being injected with an anti-nausea drug.
The question now is whether the proposed legislation has enough votes to pass, especially in the Senate where Minnesota Senator-elect Al Franken has yet to be seated.
No doubt it will be a difficult measure to muster enough votes for either in the House or Senate. Mark Hermann, a Jones Day lawyer who represents pharmaceutical and medical device companies, as well as a drug and device law blogger, noted that the federal law for medical devices contains a provision which specifically addresses the pre-empting of state laws and requirements, while the federal law pertaining to pharmaceuticals does not.
“If enacted, this legislation would effectively allow state courts to review medical devices and ultimately lead to a patchwork of inconsistent and confusing guidance on the use of medical treatments for patients and physicians, or limit their availability altogether,” wrote AdvaMed, in a news release.
Until a resolution ensues, plaintiff’s lawyers expect companies will continue seeking to dismiss liability lawsuits filed in state courts citing the Supreme Court’s 2008 decision. In January 2009, a federal judge in Minneapolis threw out lawsuits filed on behalf of thousands of patients who received heart defibrillators with wires capable of fracturing and producing lethal shocks.
Alexandra Reed writes for Connecticut personal injury law firm, Stratton Faxon. Contact Stratton Faxon to speak with a Connecticut accident lawyer about your personal injury, wrongful death, or Connecticut malpractice case. To learn more, visit Strattonfaxon.com.